Evidence map›Paper›PMID 42123223›Full record

ArticleJournal of clinical medicine2026

The Role of CD56 as an Immunophenotypic Marker in the Clinical Course of Multiple Myeloma.

Azat Karabekov, Vadim Kemaikin, Zhandos Burkitbayev, Gulnur Zhakhina, Aigerim Sipenova, Inna Berger, Ulbolsyn Orumbayeva, Zhuldyz Iskakova, Rose Ibragimova, Nazym Temir and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Azat KarabekovDepartment of Oncohematology and Bone Marrow Transplantation, National Research Oncology Center LLP, Astana 010000, Kazakhstan.ORCID 0000-0001-9281-4041
Vadim KemaikinDepartment of Oncohematology and Bone Marrow Transplantation, National Research Oncology Center LLP, Astana 010000, Kazakhstan.
Zhandos BurkitbayevNational Research Oncology Center LLP, Astana 010000, Kazakhstan.
Gulnur ZhakhinaDepartment of Medicine, Nazarbayev University School of Medicine, Astana 010000, Kazakhstan.ORCID 0000-0002-1001-1374
Aigerim SipenovaScience Management Department, National Research Oncology Center LLP, Astana 010000, Kazakhstan.
Inna BergerDepartment of Oncohematology and Bone Marrow Transplantation, Republican Specialized Scientific and Practical Center of Hematology, Tashkent 100059, Uzbekistan.
Ulbolsyn OrumbayevaUniversity Medical Center CF, Astana 010000, Kazakhstan.ORCID 0009-0003-7133-6724
Zhuldyz IskakovaDepartment of Oncohematology and Bone Marrow Transplantation, National Research Oncology Center LLP, Astana 010000, Kazakhstan.ORCID 0009-0002-6849-4273
Rose IbragimovaDepartment of Oncohematology and Bone Marrow Transplantation, National Research Oncology Center LLP, Astana 010000, Kazakhstan.
Nazym TemirDepartment of Oncohematology and Bone Marrow Transplantation, National Research Oncology Center LLP, Astana 010000, Kazakhstan.
Gulnur MamyrDepartment of Oncohematology and Bone Marrow Transplantation, National Research Oncology Center LLP, Astana 010000, Kazakhstan.
Olga KolesnikovaDepartment of Oncohematology and Bone Marrow Transplantation, National Research Oncology Center LLP, Astana 010000, Kazakhstan.
Fariza ShokubaevaDepartment of Oncohematology and Bone Marrow Transplantation, National Research Oncology Center LLP, Astana 010000, Kazakhstan.
Akbota TursynDepartment of Oncohematology and Bone Marrow Transplantation, National Research Oncology Center LLP, Astana 010000, Kazakhstan.
Meiramgul YussupovaDepartment of Oncohematology and Bone Marrow Transplantation, National Research Oncology Center LLP, Astana 010000, Kazakhstan.ORCID 0009-0005-4955-0542
Aidana ShalkarbekovaDepartment of Oncohematology and Bone Marrow Transplantation, National Research Oncology Center LLP, Astana 010000, Kazakhstan.
Ayagul AinabayDepartment of Oncohematology and Bone Marrow Transplantation, National Research Oncology Center LLP, Astana 010000, Kazakhstan.
Alexandr KolesnevDepartment of Oncohematology and Bone Marrow Transplantation, National Research Oncology Center LLP, Astana 010000, Kazakhstan.

Funding

LLP National Research Oncology center N/A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autologous stem cell transplantationCD56 expressioninduction therapy responsemultiple myelomaprognostic factors

Identifiers

PMID42123223
PMCPMC13164124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.